株式会社極東書店トップ商品一覧Targeted Molecular Imaging.

商品詳細

Targeted Molecular Imaging.

Targeted Molecular Imaging.

・ISBN 978-1-4398-4195-2 hard GB£ 235.00

¥74,448.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 9780429193590
著者・編者Welch, Michael J. / Eckelman, William C. (eds.),
シリーズ (Imaging in Medical Diagnosis and Therapy)
出版社 (CRC Press Inc, US)
出版年月2012
ページ数388 pp.
言語ENG
ニュース番号<A03-43054>

解説

Targeted Molecular Imaging covers the development of novel diagnostic approaches that use an imaging probe and agent to noninvasively visualize cellular processes in normal and disease states. It discusses the concept, development, preclinical studies, and, in many cases, translation to the clinic of targeted imaging agents.

The many case studies that form the core of this book deal with the development and translation of non-nuclear probes and radiotracers; other sections address critical topics such as In vitro studies, small animal research, and the application of targeted probes for nuclear, optical and MRI imaging. The chapters use a common format to demonstrate how various investigators approach the comprehensive task of validating a new targeted probe.

Targeted Molecular Imaging is a timely resource for a rapidly advancing field, and addresses:

  • Various methods of validating a new targeted probe through examples from human studies with imaging of breast cancer, cardiovascular disease, and neurodegenerative diseases
  • Basic principles, disease models, imaging studies in animals, imaging in initial human studies, and the application of molecular imaging in pharmacy and drug discovery
  • In vitro studies, small animal studies, and targeted radiopharmaceuticals

Using these case studies, investigators can generalize and apply the information to their own specific targeted probe. The insights provided by the contributors, experts who have developed these approaches in their own groups, help guide scientists planning to translate imaging agents from the concept stage to clinical application.